- What are the top holdings of HELX?
- Franklin Genomic Advancements ETF holds 63 securities in total. The largest positions and their portfolio weights are listed on the Holdings tab.
- How many holdings does HELX have?
- HELX holds 63 positions as reported by the fund's most recent disclosure.
- What sectors does HELX invest in?
- Franklin Genomic Advancements ETF (HELX) allocates across the sectors shown above. The largest exposure tops the list; the rest follow in descending weight order.
- What sector is HELX most exposed to?
- HELX's full sector breakdown is on the Sectors tab. The largest sector weight is shown there along with the rest of the allocation.
- Is HELX a US-only fund?
- The country allocation card on this page shows HELX's geographic exposure. Funds with > 95% US weight are effectively US-only; international or global funds will show meaningful weights across multiple countries.
- What does HELX invest in?
- This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically, it seeks out firms that the investment manager believes are fundamentally dedicated to, or are poised to significantly benefit from, efforts to prolong and enhance the overall quality of life for both humans and animals. This is accomplished by integrating cutting-edge technological and scientific innovations, improvements, and breakthroughs in the field of genomics directly into their business models and operations.
